Association of device surface and biomaterials with immunologic sensitization after mechanical support

Journal of Thoracic and Cardiovascular Surgery

Volumn 135, Issue 6, 2008, Pages

  George, Isaac ^a   Colley, Patrick ^a   Russo, Mark J ^a   Martens, Timothy P ^a   Burke, Elizabeth ^a   Oz, Mehmet C ^a   Deng, Mario C ^a   Mancini, Donna M ^a   Naka, Yoshifumi ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; HLA ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LUNG HEMODYNAMICS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIZATION; SURFACE PROPERTY; SURVIVAL TIME; TREATMENT FAILURE;

EID: 44649191660     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.11.049     Document Type: Article

References (22)

1. John R., Lietz K., Schuster M., Naka Y., Rao V., Mancini D.M., et al. Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg 125 (2003) 578-591
2. Zerbe T.R., Arena V.C., Kormos R.L., Griffith B.P., Hardesty R.L., and Duquesnoy R.J. Histocompatibility and other risk factors for histologic rejection of human cardiac allografts during the first three months following transplantation. Transplantation 52 (1991) 485-490
3. Rose E.A., Pepino P., Barr M.L., Smith C.R., Ratner A.J., Ho E., et al. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant 11 3 Pt 2 (1992) S120-S123
4. De Mattos A.M., Head M.A., Everett J., Hosenpud J., Hershberger R., Cobanoglu A., et al. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used. Transplantation 57 (1994) 626-630
5. Lavee J., Kormos R.L., Duquesnoy R.J., Zerbe T.R., Armitage J.M., Vanek M., et al. Influence of panel-reactive antibody and lymphocytotoxic cross-match on survival after heart transplantation. J Heart Lung Transplant 10 (1991) 921-930
6. Kobashigawa J.A., Sabad A., Drinkwater D., Cogert G.A., Moriguchi J.D., Kawata N., et al. Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?. Circulation 94 9 Suppl (1996) II294-II297
7. Grinda J.M., Bricourt M.O., Amrein C., Salvi S., Guillemain R., Francois A., et al. Human leukocyte antigen sensitization in ventricular assist device recipients: a lesser risk with the DeBakey axial pump. Ann Thorac Surg 80 (2005) 945-949
8. Itescu S., Tung T., Burke E., Weinberg A., Oz M., Suciu-Foca N., et al. Preformed IgG antibodies against major histocompatibility class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 98 (1998) 786-793
9. Lietz K., John R., Kocher A., Schuster M., Mancini D.M., Edwards N.M., et al. Increased prevalence of autoimmune phenomena and greater risk for alloreactivity in female heart transplant recipients. Circulation 104 Suppl 1 (2001) I177-I183
10. Rebibou J.M., Chabod J., Alcalay D., Coussediere M.C., Deteix P., Touchard G., et al. Flow cytometric evaluation of pregnancy-induced anti-HLA immunization and blood transfusion-induced reactivation. Transplantation 74 (2002) 537-540
11. Karwande S.V., Ensley R.D., Renlund D.G., Gay W.A., Richenbacher W.E., Doty D.B., et al. Cardiac retransplantation: a viable option? The Registry of the International Society for Heart and Lung Transplantation. Ann Thorac Surg 54 (1992) 840-845
12. Mehra M., Uber P.A., Uber W.E., Scott R., and Park M.H. Allosensitization in heart transplantation: implications and management strategies. Curr Opin Cardiol 18 (2003) 153-158
13. Joyce D.L., Southard R.E., Torre-Amione G., Noon G.P., Land G.A., and Loebe M. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes. J Heart Lung Transplant 24 (2005) 2054-2059
14. Itescu S., and John R. Interactions between the recipient immune system and the left ventricular assist device surface. Ann Thorac Surg 75 6 Suppl (2003) S58-S65
15. Schuster M., Kocher A.A., John R., Kukuy E., Edwards N.M., Oz M.C., et al. Allosensitization following left ventricular assist device (LVAD) implantation is dependent on CD4-CD40 ligand interactions. J Heart Lung Transplant 20 (2001) 211-212
16. Schuster M., Kocher A., John R., Hoffman M., Ankersmit J., Lietz K., et al. B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression. Hum Immunol 63 (2002) 211-220
17. Spanier T.B., Oz M.C., Rose E.A., Schmidt A.M., and Itescu S. Interactions between dendritic cells and T cells on the surface of left ventricular assist devices leads to a TH2 pattern of cytokine production and B cell hyperreactivity in vivo. Circulation 94 Suppl 8 (1996) 170
18. Deng M.C., Erren M., Tjan T.D., Tamminga N., Werntze B., Zimmermann P., et al. Left ventricular assist system support is associated with persistent inflammation and temporary immunosuppression. Thorac Cardiovasc Surg 47 Suppl 2 (1999) 326-331
19. Deng M.C., Plenz G., Labarrere C., Marboe C., Baba H.A., Erre M., et al. The role of IL-6 cytokines in acute cardiac allograft rejection. Transpl Immunol 9 (2002) 115-120
20. Thompson J.S., Thacker II L.R., and Takemoto S. The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry. Transplantation 69 (2000) 2178-2186
21. Monteiro F., Rodrigues H., Viggiani C., Fiorelli A., Stolf N., and Kalil J. Influence of pretransplant allosensitization in cardiac transplant outcome. Transplant Proc 31 (1999) 2988
22. Van Oers M., Van der Heyden A.A., and Aarden L.A. Interleukin-6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 71 (1988) 314-319